METZGER MICHAEL A (President and COO) sold 1.4% of their position (6.85K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $130.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001193125-26-253601
Officer· President and COO
Since Feb 2019
-6.85K
Net shares
Net seller
$130.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.85K
Price / share
$18.99
Trade value
$130.02K
% of position
1.4%
6/1/2026
491.69K→484.84K
Total
Net shares
−6.85K
Net value
-$130.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −6.85K | $18.99 | $130.02K | 1.4% | 491.69K | 484.84K |
| Total | −6.85K | -$130.02K | ||||||
Derivative Transactions0
No derivative transactions reported